Retatrutide Dosage Chart Retatrutide is dosed at 2 mg8 mg weekly by subcutaneous injection in educational protocols, starting low and titrating monthly
This material has not been approved by the FDA or any regulatory authority as a drug, food, dietary supplement, cosmetic, or medical product
TB 500 (Thymosin Beta-4) is one of the most abundant intracellular peptides in mammalian cells and plays a fundamental role in cytoskeletal organization
Protocol 5: neurological recovery support Goal: Support recovery from TBI, stroke, or other neurological injury Primary peptide: Cerebrolysin 10-20ml IM daily for 10-20 days (requires medical supervision) Alternatively: Semax 600-900mcg daily if Cerebrolysin unavailable Supporting peptide: BPC-157 500mcg twice daily for tissue healing Duration: Acute phase treatment, may repeat cycles as recovery progresses Considerations: Neurological injury recovery should involve medical supervision
Individual responses vary considerably based on baseline neurological status, dose, and protocol structure